|
TXG
|
10x Genomics, Inc.
|
5.48%
|
US
|
NASDAQ
|
|
1548
|
Genscript Biotech Corp
|
4.99%
|
HK
|
HK
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
4.77%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
4.72%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
4.60%
|
US
|
NASDAQ
|
|
QGEN
|
Qiagen N.V.
|
4.54%
|
US
|
NYSE
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
4.52%
|
US
|
NASDAQ
|
|
TECH
|
Techne Corporation
|
4.42%
|
US
|
NASDAQ
|
|
BNTX
|
BioNTech SE
|
4.42%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
4.33%
|
US
|
NASDAQ
|
|
A
|
Agilent Technologies, Inc.
|
4.33%
|
US
|
NYSE
|
|
CRSP
|
CRISPR Therapeutics AG
|
3.46%
|
US
|
NASDAQ
|
|
BEAM
|
Beam Therapeutics Inc.
|
3.44%
|
US
|
NASDAQ
|
|
ILMN
|
Illumina, Inc.
|
3.43%
|
US
|
NASDAQ
|
|
NTRA
|
Natera, Inc.
|
3.22%
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
2.93%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
2.91%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
2.70%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
2.57%
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
2.52%
|
US
|
NASDAQ
|